利润表（达安基因）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 853,024,340.06 | 591,050,057.91 | 400,381,368.24 | 198,307,676.45 | 1,180,897,087.04 | 842,336,232.83 | 536,218,449.35 | 341,038,087.62 |
| 营业收入(元) | 853,024,340.06 | 591,050,057.91 | 400,381,368.24 | 198,307,676.45 | 1,180,897,087.04 | 842,336,232.83 | 536,218,449.35 | 341,038,087.62 |
| 二、营业总成本(元) | 1,058,064,537.31 | 695,779,975.01 | 454,312,338.72 | 207,951,519.66 | 1,133,440,757.45 | 822,995,285.90 | 554,210,715.32 | 331,655,918.97 |
| 营业成本(元) | 532,743,357.51 | 354,750,208.80 | 235,349,667.91 | 87,581,209.69 | 584,929,093.72 | 380,716,762.30 | 252,528,902.45 | 150,889,525.36 |
| 研发费用(元) | 225,668,337.11 | 167,134,295.16 | 118,905,329.41 | 56,401,238.80 | 302,332,171.04 | 222,724,481.01 | 151,908,136.77 | 76,407,740.73 |
| 营业税金及附加(元) | 9,533,974.98 | 4,212,451.30 | 2,786,935.40 | 1,223,206.73 | 9,781,719.09 | 4,600,340.02 | 2,853,237.54 | 1,264,795.54 |
| 销售费用(元) | 208,135,259.78 | 105,810,189.55 | 62,995,789.03 | 25,419,046.72 | 172,833,278.42 | 135,653,918.48 | 102,470,794.71 | 53,169,470.42 |
| 管理费用(元) | 147,052,511.51 | 111,681,235.85 | 68,056,335.76 | 53,414,419.96 | 138,313,374.00 | 140,633,040.10 | 97,853,479.80 | 61,615,003.12 |
| 财务费用(元) | -65,068,903.58 | -47,808,405.65 | -33,781,718.79 | -16,087,602.24 | -74,748,878.82 | -61,333,256.01 | -53,403,835.95 | -11,690,616.19 |
| 其中：利息费用(元) | 9,744,538.33 | 5,742,298.28 | 4,457,798.91 | 2,157,240.10 | 10,042,125.86 | 5,106,898.21 | 2,809,252.37 | 1,191,644.09 |
| 三、其他经营收益 | ||||||||
| 加：公允价值变动收益(元) | -175,745,759.40 | -119,224,149.48 | -306,861,205.58 | -365,572,891.12 | 435,690,646.25 | 403,291,564.96 | 479,960,170.65 | 23,574,185.76 |
| 加：投资收益(元) | -253,838,060.16 | -130,108,689.20 | -29,960,605.45 | -22,096,061.02 | -26,246,655.88 | -334,952.78 | 20,089,978.44 | -13,106,754.85 |
| 其中：对联营企业和合营企业的投资收益(元) | -271,330,674.70 | -145,104,408.39 | -45,144,034.50 | -25,864,186.87 | -46,100,751.43 | -13,597,195.40 | 6,900,566.54 | -15,938,091.21 |
| 资产处置收益(元) | 9,096,715.23 | 2,077,739.90 | -1,160,087.84 | -617,064.09 | -3,039,675.21 | -110,841.37 | - | - |
| 资产减值损失(元) | -75,039,742.89 | -113,954.43 | -85,860.45 | 54,409.17 | -262,753,953.87 | -24,413,320.63 | -15,050,080.38 | - |
| 信用减值损失(元) | -407,831,786.93 | -247,295,765.62 | -107,629,286.33 | -48,499,214.15 | -153,689,485.16 | -44,191,268.59 | -682,891.61 | 13,206,106.57 |
| 其他收益(元) | 40,793,337.41 | 32,632,643.94 | 24,890,695.65 | 13,067,801.74 | 84,204,656.30 | 77,951,811.63 | 22,775,318.86 | 17,467,342.87 |
| 四、营业利润(元) | -1,067,605,493.99 | -566,762,091.99 | -474,737,320.48 | -433,306,862.68 | 121,621,862.02 | 431,533,940.15 | 489,100,229.99 | 50,523,049.00 |
| 加：营业外收入(元) | 2,584,173.89 | 436,836.52 | 128,416.31 | 126,532.41 | 1,889,579.20 | 1,534,885.17 | 1,493,868.76 | 57,193.02 |
| 减：营业外支出(元) | 6,142,074.30 | 1,552,357.49 | 1,406,707.59 | 887,742.33 | 9,975,491.46 | 3,485,967.15 | 3,282,090.18 | 655,060.36 |
| 五、利润总额(元) | -1,071,163,394.40 | -567,877,612.96 | -476,015,611.76 | -434,068,072.60 | 113,535,949.76 | 429,582,858.17 | 487,312,008.57 | 49,925,181.66 |
| 减：所得税费用(元) | -132,050,533.38 | -66,376,049.48 | -78,369,791.08 | -72,927,188.70 | 41,804,363.65 | 83,479,779.01 | 88,919,291.85 | 12,147,268.96 |
| 六、净利润(元) | -939,112,861.02 | -501,501,563.48 | -397,645,820.68 | -361,140,883.90 | 71,731,586.11 | 346,103,079.16 | 398,392,716.72 | 37,777,912.70 |
| (一)按经营持续性分类 | ||||||||
| 持续经营净利润(元) | -939,112,861.02 | -501,501,563.48 | -397,645,820.68 | -361,140,883.90 | 71,731,586.11 | 346,103,079.16 | 398,392,716.72 | 37,777,912.70 |
| (二)按所有权归属分类 | ||||||||
| 归属于母公司股东的净利润(元) | -925,169,864.75 | -502,719,727.25 | -399,219,058.46 | -363,290,638.81 | 104,659,624.06 | 352,594,428.71 | 402,755,388.71 | 36,561,352.66 |
| 少数股东损益(元) | -13,942,996.27 | 1,218,163.77 | 1,573,237.78 | 2,149,754.91 | -32,928,037.95 | -6,491,349.55 | -4,362,671.99 | 1,216,560.04 |
| 扣除非经常性损益后的净利润(元) | -822,653,095.84 | -432,847,055.74 | -178,752,096.86 | -69,813,961.85 | -363,823,780.35 | 27,959,457.16 | 102,897,120.82 | 18,291,516.52 |
| 七、每股收益 | ||||||||
| 一、基本每股收益(元) | -0.66 | -0.36 | -0.28 | -0.26 | 0.07 | 0.25 | 0.29 | 0.03 |
| 二、稀释每股收益(元) | -0.66 | -0.36 | -0.28 | -0.26 | 0.07 | 0.25 | 0.29 | 0.03 |
| 八、其他综合收益(元) | -3,309,277.01 | 125,820.15 | 485,109.64 | 220,519.57 | -867,076.31 | 423,297.85 | 400,942.90 | -369,592.19 |
| 归属于母公司股东的其他综合收益(元) | -3,491,876.88 | 162,725.34 | 445,072.40 | 223,605.54 | -1,067,187.13 | 248,466.26 | 192,555.76 | -258,428.99 |
| 归属于少数股东的其他综合收益(元) | 182,599.87 | -36,905.19 | 40,037.24 | -3,085.97 | 200,110.82 | 174,831.59 | 208,387.14 | -111,163.20 |
| 九、综合收益总额(元) | -942,422,138.03 | -501,375,743.33 | -397,160,711.04 | -360,920,364.33 | 70,864,509.80 | 346,526,377.01 | 398,793,659.62 | 37,408,320.51 |
| 归属于母公司所有者的综合收益总额(元) | -928,661,741.63 | -502,557,001.91 | -398,773,986.06 | -363,067,033.27 | 103,592,436.93 | 352,842,894.97 | 402,947,944.47 | 36,302,923.67 |
| 归属于少数股东的综合收益总额(元) | -13,760,396.40 | 1,181,258.58 | 1,613,275.02 | 2,146,668.94 | -32,727,927.13 | -6,316,517.96 | -4,154,284.85 | 1,105,396.84 |
| 公告日期 | 2025-03-29 | 2024-10-31 | 2024-08-31 | 2024-04-30 | 2024-03-30 | 2023-10-31 | 2023-08-31 | 2023-04-29 |
| 审计意见(境内) | 标准无保留意见 | - | - | - | 标准无保留意见 | - | - | - |
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 八、其他综合收益(元) |
| 归属于母公司股东的其他综合收益(元) |
| 归属于少数股东的其他综合收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 44 of 44 entries